Cutaneous Melanoma – A Review of Systemic Therapies

Cutaneous Melanoma – A Review of Systemic Therapies

This decade has brought significantly improved outcomes for patients with advanced melanoma with immunotherapies and targeted treatments offering utility in a variety of settings. In 2020, we can hope for durable long-term responses, and complete remission in a subset of patients with metastatic dis...

Full description

Bibliographic Details
Main Authors:	Karla A. Lee, Paul Nathan
Format:	Article
Language:	English
Published:	Society for Publication of Acta Dermato-Venereologica 2020-06-01
Series:	Acta Dermato-Venereologica
Subjects:	melanoma systemic therapy targeted therapy immunotherapy
Online Access:	https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3496

Similar Items

Obesity and the Impact on Cutaneous Melanoma: Friend or Foe?
by: Lorey K. Smith, et al.
Published: (2020-06-01)

Advances in Targeting Cutaneous Melanoma
by: Dimitri Kasakovski, et al.
Published: (2021-04-01)

miRNAs as Key Players in the Management of Cutaneous Melanoma
by: Celeste Lorusso, et al.
Published: (2020-02-01)

Contemporary Neoadjuvant Therapies for High-Risk Melanoma: A Systematic Review
by: Kerianne Boulva, et al.
Published: (2021-04-01)

Targeted Therapy for Cutaneous Melanoma: Beyond BRAF...
by: Michael A. Davies
Published: (2014-01-01)

Nanosystems for Improved Targeted Therapies in Melanoma
by: Cristina Beiu, et al.
Published: (2020-01-01)

Melanoma Plasticity: Promoter of Metastasis and Resistance to Therapy
by: Fan Huang, et al.
Published: (2021-09-01)

Biomarkers Predicting for Response and Relapse with Melanoma Systemic Therapy
by: Sarah J. Welsh, et al.
Published: (2020-06-01)

Adjuvant Therapy for Melanoma: Past, Current, and Future Developments
by: Alessandro A. E. Testori, et al.
Published: (2020-07-01)

Molecular background of skin melanoma development and progression: therapeutic implications
by: Magdalena Olbryt
Published: (2019-05-01)

Uncommon Subtypes of Malignant Melanomas: A Review Based on Clinical and Molecular Perspectives
by: Matías Chacón, et al.
Published: (2020-08-01)

BRAF Gene and Melanoma: Back to the Future
by: Margaret Ottaviano, et al.
Published: (2021-03-01)

Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs
by: Brenda Leeneman, et al.
Published: (2020-04-01)

The Great Debate at “Melanoma Bridge”, Napoli, December 2nd, 2017
by: Paolo A. Ascierto, et al.
Published: (2018-04-01)

Biological therapy in the treatment of melanoma
by: Simona-Roxana Georgescu, et al.
Published: (2018-10-01)

Liquid biomarkers in melanoma: detection and discovery
by: Su Yin Lim, et al.
Published: (2018-01-01)

Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy
by: Italia Falcone, et al.
Published: (2020-10-01)

Modern options in personalized therapy of metastatic cutaneous melanoma
by: S A Protsenko, et al.
Published: (2014-09-01)

Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal Metastases
by: Pauline Tétu, et al.
Published: (2020-09-01)

Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November–2 December, 2017, Naples, Italy)
by: Paolo A. Ascierto, et al.
Published: (2018-07-01)

Overall Survival Improved for Contemporary Patients with Melanoma: A 2004–2015 National Cancer Database Analysis
by: Norma E. Farrow, et al.
Published: (2020-05-01)

Recent Advances in Nanotechnology for the Treatment of Melanoma
by: Roberta Cassano, et al.
Published: (2021-02-01)

Updates in Therapy for Advanced Melanoma
by: Bhavana P. Singh, et al.
Published: (2016-01-01)

Identifying High-Risk Tumors within AJCC Stage IB–III Melanomas Using a Seven-Marker Immunohistochemical Signature
by: Robin Reschke, et al.
Published: (2021-06-01)

Sequential Treatment With Targeted and Immune Checkpoint Therapy in Patients With BRAF Positive Metastatic Melanoma: The Importance of Timing?
by: Victoria Grätz, et al.
Published: (2019-12-01)

Decreased survival in patients treated by chemotherapy after targeted therapy compared to immunotherapy in metastatic melanoma
by: Marie‐Alix Mangin, et al.
Published: (2021-05-01)

Clinical and Pathological Relevance of Drug-induced Vitiligo in Patients Treated for Metastatic Melanoma with Anti-PD1 or BRAF/MEK Inhibitors
by: Alice Ramondetta, et al.
Published: (2020-01-01)

Treatment of BRAF-Mutated Metastatic Melanoma: Immunotherapy or Target Therapy?
by: Ana Sofia Rodrigues, et al.
Published: (2021-06-01)

Melanoma treatment in review
by: Domingues B, et al.
Published: (2018-06-01)

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma
by: Giuseppe Palmieri, et al.
Published: (2021-07-01)

Treatment of malignant melanoma - a review of the literature
by: Natalia Kluz, et al.
Published: (2021-09-01)

Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma
by: Chune Yu, et al.
Published: (2019-05-01)

CURRENT CONCEPTS IN THERAPY OF UVEAL MELANOMA
by: Detanac Dženana A, et al.
Published: (2015-07-01)

DISSEMINATED CUTANEOUS MELANOMA: URGENCY OF AN ISSUE, INCIDENCE, TREATMENT PERSPECTIVE (LITERATURE REVIEW)
by: R. A. Murashko, et al.
Published: (2019-02-01)

Melanoma: Attacking on Many Fronts
by: Michael A. Thompson
Published: (2014-01-01)

The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options
by: Emmanuel Gabriel, et al.
Published: (2015-07-01)

Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy—A retrospective cohort study
by: Brigitte Gatterbauer, et al.
Published: (2020-06-01)

Cutaneous Adverse Events of Targeted Therapies and Immune-Checkpoint Inhibitors in Patients with Melanoma
by: Rita Pimenta, et al.
Published: (2021-04-01)

The Challenges of Melanoma during COVID-19 Pandemic
by: Raluca-Gabriela MIULESCU, et al.
Published: (2020-09-01)

Sex-Based Differences in Treatment with Immune Checkpoint Inhibition and Targeted Therapy for Advanced Melanoma: A Nationwide Cohort Study
by: Monique K. van der Kooij, et al.
Published: (2021-09-01)